Latest stories on DNTH
DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results
Stocktwits News77 · bullishproduct/pr
Dianthus Highlights Positive CAPTIVATE Phase 3 Interim Results
TipRanks67 · bullishproduct/pr
Dianthus Therapeutics, Inc. /DE/ (DNTH) files 8-K
SEC 8-K50 · neutralgeneral
Dianthus Therapeutics: Sanofi's CIPD Study Fail Poses Uncomfortable Questions
Seeking Alpha42 · neutralproduct/pr
Dianthus drops as Sanofi halts late-stage trial for CIDP therapy on efficacy concerns
Seeking Alpha33 · bearishgeneral
Dianthus Therapeutics, Inc. (DNTH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha53 · neutralproduct/pr
Dianthus Therapeutics (DNTH) Appears Attractive Amid Solid Product Pipeline
Yahoo Top61 · neutralanalyst
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | DNTH Stock News
StockTitan50 · neutralgeneral
Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win
Seeking Alpha61 · neutralproduct/pr
Dianthus Therapeutics to Participate in Two Investor Conferences | DNTH Stock News
StockTitan53 · neutralproduct/pr
Dianthus Therapeutics Stockholders Reaffirm Board and Governance Structure
TipRanks50 · neutralgeneral